```html

Quilted Dermatitis (Retiform Purpura): A Comprehensive Medical Guide

Overview

Quilted dermatitis, more commonly referred to in the dermatology literature as retiform purpura, is a distinctive skin finding characterized by a net‑like (retiform) pattern of purplish‑red bruising that resembles a quilted fabric. The lesions are typically non‑blanching, often painful or tender, and can evolve into necrotic (dead) skin if the underlying vascular problem is not corrected.

Retiform purpura is not a single disease; it is a clinical sign that appears when blood vessels in the skin become obstructed or damaged, leading to extravasation of red blood cells. It can be seen in a wide spectrum of conditions ranging from benign vasculitis to life‑threatening disseminated intravascular coagulation (DIC).

Who it affects: The condition can occur at any age, but the underlying causes differ by age group. In adults, especially those over 50, it’s most often linked to systemic vascular disorders, malignancies, or medication‑induced coagulation abnormalities. In children, infections (e.g., meningococcemia) and inherited clotting disorders are more common triggers.

Prevalence: Precise epidemiologic data are limited because retiform purpura is a symptom rather than a primary disease. However, case series from tertiary dermatology centers suggest it accounts for roughly 1‑2 % of all patients evaluated for unexplained purpura, and up to 10 % of skin findings in patients with severe sepsis or DIC.<sup>[1] Mayo Clinic</sup>

Symptoms

The hallmark sign is the patterned purpura itself, but several associated symptoms can help differentiate the underlying cause.

Skin Findings

• Retiform (net‑like) purpura: Irregular, branching patches of non‑blanching purple or reddish‑brown discoloration that follow the course of cutaneous vessels.
• Quilted appearance: The lesions may have raised, indurated borders that give a “fabric‑like” look.
• Evolution: Lesions can progress from flat discoloration to raised papules, then to hemorrhagic vesicles or necrotic ulcers.
• Distribution: Commonly involves the lower extremities, thighs, buttocks, and sometimes the trunk; sparing of the palms and soles is typical.

Systemic Symptoms

• Pain or tenderness over the lesions (often severe).
• Fever, chills, or night sweats when infection or vasculitis is present.
• Joint pain or swelling (suggesting systemic vasculitis).
• Shortness of breath, chest pain, or leg swelling if a thrombotic source exists.
• Neurologic changes (headache, confusion) in cases related to severe coagulopathy or meningococcemia.

Associated Laboratory Findings

• Elevated inflammatory markers (ESR, CRP).
• Abnormal coagulation profile (elevated D‑dimer, prolonged PT/PTT).
• Low platelet count in DIC or drug‑induced thrombocytopenia.
• Positive auto‑antibodies (ANCA, ANA) in autoimmune vasculitis.

Causes and Risk Factors

Retiform purpura is a manifestation of an underlying vascular or hematologic disturbance. The following categories summarize the most common causes.

1. Thrombotic Causes

• Disseminated Intravascular Coagulation (DIC): Often secondary to severe infection, trauma, or malignancy.
• Antiphospholipid Syndrome (APS): Autoimmune clotting disorder that predisposes to arterial and venous thrombosis.
• Hypercoagulable states: Factor V Leiden, prothrombin gene mutation, protein C/S deficiency.
• Medications: Warfarin skin necrosis, heparin‑induced thrombocytopenia (HIT), oral contraceptives.

2. Vasculitic Causes

• IgA vasculitis (Henoch‑Schönlein purpura).
• ANCA‑associated vasculitis (e.g., microscopic polyangiitis, granulomatosis with polyangiitis).
• Cryoglobulinemic vasculitis (often linked to hepatitis C).
• Hypersensitivity (drug‑induced) vasculitis.

3. Infectious Causes

• Severe bacterial infections – meningococcemia, streptococcal toxic shock.
• Viral infections – HIV, hepatitis B/C, parvovirus B19.
• Endocarditis‑related emboli.

4. Malignancy‑related Causes

• Cutaneous involvement of hematologic cancers (leukemia, lymphoma).
• Paraneoplastic vasculitis associated with solid tumors (lung, breast, gastrointestinal).

Risk Factors

• Age > 50 years.
• Underlying autoimmune disease (e.g., systemic lupus erythematosus).
• Recent surgery, immobilization, or long‑distance travel.
• Use of hormonal therapy or chemotherapy.
• Chronic kidney disease or liver dysfunction (altered coagulation).

Diagnosis

Because retiform purpura is a sign rather than a disease, diagnosis focuses on uncovering the root cause.

Clinical Evaluation

• History: Onset, progression, associated systemic symptoms, medication list, recent infections or surgeries.
• Physical exam: Detailed skin inspection, assessment of pulse, temperature, and any signs of systemic illness.

Laboratory Tests

• Complete blood count (CBC) with differential.
• Comprehensive metabolic panel (CMP) – liver/kidney function.
• Coagulation profile: PT, aPTT, INR, fibrinogen, D‑dimer.
• Inflammatory markers: ESR, CRP.
• Autoimmune serologies: ANA, ANCA, antiphospholipid antibodies, complement levels.
• Blood cultures if infection is suspected.
• Thrombophilia screen (factor V Leiden, prothrombin mutation, protein C/S, antithrombin).

Imaging

• Duplex ultrasonography or CT angiography if large‑vessel thrombosis or emboli are suspected.
• Chest X‑ray or CT to evaluate for pneumonia, mediastinal masses, or pulmonary embolism.

Skin Biopsy

A 4‑mm punch biopsy taken from the active edge of a lesion (preferably before necrosis) is essential when the cause is unclear.

• Histopathology: May show leukocytoclastic vasculitis, fibrinoid necrosis, thrombosis of dermal vessels, or deposition of immune complexes.
• Direct immunofluorescence can detect IgA, IgM, C3 deposits – useful for IgA vasculitis or lupus.

Diagnostic Algorithm (simplified)

1. Identify retiform purpura on exam.
2. Rule out emergent causes (DIC, severe infection) with CBC, coag studies, blood cultures.
3. Obtain autoimmune panel if vasculitis suspected.
4. Perform skin biopsy if labs are nondiagnostic.
5. Coordinate with hematology, rheumatology, or infectious disease specialists for targeted work‑up.

Treatment Options

Treatment is two‑fold: address the underlying etiology and provide supportive care for the skin lesions.

1. Management of Underlying Cause

Thrombotic Disorders

• Anticoagulation: Low‑molecular‑weight heparin (LMWH) or direct oral anticoagulants (DOACs) for confirmed thrombosis or APS.
• Warfarin skin necrosis: Immediate cessation of warfarin, start LMWH, and give vitamin K.
• HIT: Stop all heparin products; initiate non‑heparin anticoagulants (argatroban, bivalirudin).

Vasculitis

• Systemic corticosteroids: Prednisone 0.5‑1 mg/kg/day for acute control.
• Immunosuppressants: Azathioprine, methotrexate, or cyclophosphamide for severe or ANCA‑associated disease.
• Biologics: Rituximab (especially for ANCA vasculitis) or IVIG for refractory cases.

Infection‑Related

• Broad‑spectrum antibiotics pending cultures (e.g., ceftriaxone + vancomycin for meningococcemia).
• Targeted antimicrobial therapy once pathogen identified.
• Supportive measures for sepsis – fluids, vasopressors as needed.

Malignancy‑Associated

• Oncologic therapy (chemotherapy, targeted agents) directed at the primary tumor.
• Paraneoplastic vasculitis often improves with tumor control.

2. Local Skin Care

• Gentle cleansing with mild soap; avoid harsh scrubbing.
• Apply non‑adherent dressings (e.g., silicone‑gel or hydrocolloid) to protect ulcerated areas.
• Topical antimicrobials (mupirocin) if secondary bacterial infection suspected.
• Pain control – acetaminophen, NSAIDs (if not contraindicated), or low‑dose opioids for severe pain.

3. Supportive Measures

• Compression therapy only if venous insufficiency is confirmed and no active arterial occlusion.
• Elevate affected limbs to reduce edema.
• Maintain optimal nutrition (protein > 1.2 g/kg) to promote wound healing.
• Smoking cessation – smoking worsens microvascular disease.

Living with Quilted Dermatitis (Retiform Purpura)

While the skin lesions can be distressing, many patients can lead active lives once the underlying condition is controlled.

Daily Management Tips

• Skin inspection: Perform a self‑check of affected areas twice daily; note any new bruising, pain, or drainage.
• Wound care: Change dressings at least every 24 hours or sooner if soiled.
• Medication adherence: Keep a medication log; use pill organizers or smartphone alarms.
• Hydration: Aim for at least 2 L of water daily unless fluid restriction is ordered.
• Physical activity: Gentle walking or range‑of‑motion exercises improve circulation; avoid prolonged standing or immobility.
• Temperature moderation: Extreme heat can exacerbate vasodilation and swelling; keep rooms comfortably cool.
• Psychological support: Chronic skin disease can impact mood; consider counseling or support groups.

When to Call Your Provider

• Rapid expansion of purpura or development of black, necrotic tissue.
• Fever > 38 °C (100.4 °F) or chills.
• Increasing pain despite analgesics.
• New shortness of breath, chest pain, or leg swelling.
• Any signs of bleeding elsewhere (e.g., gums, urine).

Prevention

Because retiform purpura is secondary, prevention focuses on minimizing the risk of the underlying triggers.

• Manage chronic diseases (diabetes, hypertension, hyperlipidemia) to preserve vascular health.
• Regularly review medications with your clinician; avoid unnecessary high‑dose steroids or anticoagulants without indication.
• Vaccinations (influenza, pneumococcal, COVID‑19) reduce infection‑related sepsis.
• Adopt a heart‑healthy lifestyle: balanced diet, regular exercise, weight control.
• For patients with known hypercoagulable states, adhere to prescribed anticoagulation regimens and monitor INR if on warfarin.
• Prompt treatment of skin infections or injuries to avoid secondary vascular compromise.

Complications

If the underlying cause is not identified or treated promptly, several serious complications may arise.

• Skin necrosis and ulceration: May require surgical debridement or grafting.
• Secondary bacterial infection: Can lead to cellulitis, abscess formation, or sepsis.
• Systemic thrombosis: Deep vein thrombosis, pulmonary embolism, or arterial occlusion.
• Organ damage: In DIC or severe vasculitis, kidneys, lungs, or brain may be compromised.
• Chronic pain or scarring: May affect mobility and quality of life.
• Mortality: In the setting of fulminant sepsis or massive DIC, mortality can exceed 30 %.<sup>[2] CDC</sup>

When to Seek Emergency Care

Immediate emergency evaluation is needed if you experience any of the following:

• Sudden, severe spreading of the purpuric pattern with areas turning black or blistered.
• High fever (> 39 °C / 102 °F) combined with rapid heart rate (> 120 bpm) or low blood pressure (systolic < 90 mmHg).
• Shortness of breath, chest pain, or sudden leg swelling – signs of pulmonary embolism or deep‑vein thrombosis.
• Severe, unrelenting pain that does not improve with prescribed analgesics.
• Bleeding from the skin lesions or other sites (gums, urine, stool).
• Altered mental status, confusion, or seizures.

Call 911 or go to the nearest emergency department. Prompt treatment can be life‑saving.

References

1. Mayo Clinic. “Purpura and Petechiae.” Accessed May 2024. https://www.mayoclinic.org
2. Centers for Disease Control and Prevention. “Disseminated Intravascular Coagulation (DIC).” 2023. https://www.cdc.gov
3. National Institutes of Health. “Antiphospholipid Syndrome.” Updated 2022. https://www.nih.gov
4. Cleveland Clinic. “Vasculitis.” 2024. https://my.clevelandclinic.org
5. World Health Organization. “Guidelines for the Management of Sepsis.” 2023. https://www.who.int

```